Muhdo AI Strategy | Genomics & Multi-Omics Intelligent Analysis
AI Strategy Capabilities Model Training Applications Roadmap Explore Muhdo Tests
Glowing DNA double helix built from purple and blue particles with a protein wireframe grid
Muhdo AI Strategy

Genomics & Multi-Omics Intelligence
for the Next Generation of Personalised Health

Muhdo is combining years of genetic and multi-omics data expertise with artificial intelligence, training private clinical decision models that move health guidance from generic reports towards individualised, intelligent support.

0Multi-omics data dimensions
0Core model training stages
0AI capability pillars
0Privately deployed models
Our AI Strategy

From Genetic Testing to Intelligent Health Decisions

Muhdo's AI upgrade is not about bolting on a generic model. It is built on our own compliant data assets, forming a private intelligence engine that keeps improving.

Data Assets

Years of genetic and epigenetic testing have produced rich multi-omics data, de-identified and governed into trainable assets.

Intelligence Engine

Private clinical decision models are trained and validated in our own environment, keeping capability in-house and continuously iterated.

Health Decisions

Model outputs provide individualised health risk assessments and interpretations, supporting professionals and clients in understanding their data.

Core Capabilities

Three Core Capabilities

A complete AI stack spanning data, structure and decision-making.

Genomics & Multi-Omics Analysis

Integrating genomics, DNA methylation, transcriptomics, proteomics and metabolomics layers to mine individualised features.

  • Multi-omics standardisation and integration
  • Individualised feature mining and association analysis
  • Feature atlases built for health interpretation

Protein Structure Prediction

Deep-learning-based 3D protein structure prediction and functional annotation, supporting target understanding and intervention research.

  • 3D structure prediction with confidence scoring
  • Functional site annotation and alignment
  • Batch prediction support for research programmes

Private Clinical Decision Model Training

Training private models on our own compliant data to deliver individualised health risk assessments and guidance support.

  • Private-environment training and deployment
  • Clinical experts involved in validation
  • Continuous iteration with version control
Private Model Training

Private Clinical Decision Model Training

A complete, auditable training pipeline that grounds model capability in our own data and expert validation.

1

Multi-Source Data Collection & Governance

Multi-omics testing data enters the training pool after de-identification and compliant governance.

2

Multi-Omics Feature Engineering

Cross-omics feature alignment, standardisation and individualised feature atlas construction.

3

Model Training & Clinical Validation

Trained in our private environment, with clinical experts reviewing results and bias.

4

Private Deployment & Iteration

Models run in our own environment, iterated and monitored by version.

Privacy first · de-identified, compliant data handling Private models · no reliance on third-party general models Expert validation · clinical experts in the review loop
Why Muhdo

Technical Advantages & Differentiation

Proprietary Data Assets

Multi-omics data accumulated over years of testing forms a training foundation general-purpose models cannot access.

Privacy & Security

De-identification, pseudonymisation and access control run through the entire pipeline, in line with applicable privacy regulations.

In-House, Controllable Models

Training, validation and deployment all happen in our own environment, so capability improves as data accumulates.

Clinical Grounding

Medical and scientific experts take part in model validation; outputs are positioned as supportive reference, not diagnostic conclusions.

Applications

Application Scenarios

Personalised genomic health report dashboard on screen

Upgraded Personalised Health Reports

AI-enhanced interpretation for our existing test products, bringing reports closer to each individual.

Health risk analytics dashboard with glowing charts

Intelligent Health Risk Assessment

Individualised risk insights for consumers, supporting personal health planning.

Laboratory sequencing machine with research screens

Research & Industry Collaboration

Multi-omics analysis and protein structure prediction support for healthcare and pharma partners.

Roadmap

Development Roadmap

Phase 01

Multi-Omics Data Platform Integration

Complete standardised governance of multi-omics data and build a unified feature platform.

Phase 02

First Private Clinical Decision Model Live

Finish the first training round and clinical expert validation, deployed in our own environment.

Phase 03

AI-Enhanced Health Reports Released

Connect model interpretation into the reporting system of existing test products.

Phase 04

Open Research Collaboration Ecosystem

Open multi-omics analysis and structure prediction collaboration to healthcare and industry partners.

Muhdo AI handles data in line with applicable privacy regulations. Model outputs are provided for health reference only and do not constitute a medical diagnosis. Partner and certification details are as officially published.

LAB PARTNERUNIVERSITYRESEARCH CONSORTIUMISO 17025:2005

Step into the Intelligent Health Era with Muhdo

Learn about our AI strategy, or talk to us about research and industry collaboration.